Research and Development

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …

Swedish specialty pharmaceutical company Medivir has appointed Charlotte Edenius to the newly created position of VP of research and development …

Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …

US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …

Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …

The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …

Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …

Lundbeck UK has formed a new senior management team, appointing Steve Ferguson, Andy Davis, Andy Jones, Helen Carberry and Amanda …

Mid-stage trial results of Abbott Laboratories’ oral hepatitis C drug ABT-450/r have impressed at the American Liver Disease congress. The …

The head of the FDA has declared a need for ‘regulatory science’ to catch up with the advances in medical …

Two initiatives linking the pharma industry and government-funded research and academia are to go ahead, with the aim of reviving …

Regulation! Regulation! Regulation! Never has our business been more highly regulated than it is today. Seemingly, rules change every day. …

UK government funding for life sciences R&D has been spared from the deep cuts some had feared. Many in the …